Format

Send to

Choose Destination
CPT Pharmacometrics Syst Pharmacol. 2017 Nov;6(11):732-746. doi: 10.1002/psp4.12230. Epub 2017 Sep 8.

Integration of Genome Scale Metabolic Networks and Gene Regulation of Metabolic Enzymes With Physiologically Based Pharmacokinetics.

Author information

1
School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, UK.
2
Quantitative Systems Pharmacology, Simcyp Limited (A Certara Company), Blades Enterprise Centre, Sheffield, UK.
3
Translational Science and DMPK, Simcyp Limited (A Certara Company), Blades Enterprise Centre, Sheffield, UK.
4
School of Food Science and Nutrition, Faculty of Mathematics and Physical Sciences, University of Leeds, Leeds, UK.
5
School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.

Abstract

The scope of physiologically based pharmacokinetic (PBPK) modeling can be expanded by assimilation of the mechanistic models of intracellular processes from systems biology field. The genome scale metabolic networks (GSMNs) represent a whole set of metabolic enzymes expressed in human tissues. Dynamic models of the gene regulation of key drug metabolism enzymes are available. Here, we introduce GSMNs and review ongoing work on integration of PBPK, GSMNs, and metabolic gene regulation. We demonstrate example models.

PMID:
28782239
PMCID:
PMC5702902
DOI:
10.1002/psp4.12230
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center